In conclusion, this updated meta‐analysis of ~17 000 HF patients shows that SGLT2 inhibitors significantly decrease HF hospitalizations, adverse renal outcomes, and mortality in patients with HF. Here, SLC5A2 is linked to hydrops fetalis.